Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Identification of Pik3ca Mutation as a Genetic Driver of Prostate Cancer That Cooperates with Pten Loss to Accelerate Progression and Castration-Resistant Growth.

Pearson HB, Li J, Meniel VS, Fennell CM, Waring P, Montgomery KG, Rebello RJ, Macpherson AA, Koushyar S, Furic L, Cullinane C, Clarkson RW, Smalley MJ, Simpson KJ, Phesse TJ, Shepherd PR, Humbert PO, Sansom OJ, Phillips WA.

Cancer Discov. 2018 Jun;8(6):764-779. doi: 10.1158/2159-8290.CD-17-0867. Epub 2018 Mar 26.

PMID:
29581176
2.

The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells.

Koushyar S, Economides G, Zaat S, Jiang W, Bevan CL, Dart DA.

Oncogenesis. 2017 May 15;6(5):e333. doi: 10.1038/oncsis.2017.32.

3.

The interaction of Wnt-11 and signalling cascades in prostate cancer.

Koushyar S, Grant GH, Uysal-Onganer P.

Tumour Biol. 2016 Oct;37(10):13049-13057. Epub 2016 Aug 11. Review.

PMID:
27514543
4.

Unveiling the potential of prohibitin in cancer.

Koushyar S, Jiang WG, Dart DA.

Cancer Lett. 2015 Dec 28;369(2):316-22. doi: 10.1016/j.canlet.2015.09.012. Epub 2015 Oct 9. Review.

5.

Clinical and radiological findings following continent urinary diversion with colonic segment in dog.

Koushyar SH, Saberi Afshar F, Ghadiri AR.

Pak J Biol Sci. 2007 Sep 15;10(18):3091-6.

PMID:
19090104

Supplemental Content

Loading ...
Support Center